Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q1 2026: Eli Lilly 19.799, Novo Nordisk 14.911.
Eli Lilly vs Novo Nordisk Net Worth and Market Cap
Eli Lilly (LLY) and Novo Nordisk (NVO) are peers in GLP-1. Eli Lilly reported revenue of $19.8B as of Q1 2026, compared with $14.9B for Novo Nordisk. Eli Lilly leads on revenue.
Eli Lilly's gross margin is 81.9% versus 86.0% for Novo Nordisk. Eli Lilly's net margin is 37.4% versus 50.1% for Novo Nordisk.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Eli Lilly, Novo Nordisk.| Metric | Eli Lilly | Novo Nordisk |
|---|---|---|
| Market Cap | - | - |
| Revenue | $19.80B | $14.91B |
| Cost of Revenue | $3.58B | $2.09B |
| Gross Profit | $16.22B | $12.82B |
| Operating Income | $8.85B | $9.18B |
| Net Income | $7.40B | $7.48B |
| R&D Expense | $3.51B | $1.58B |
| Earnings Per Share | $8.26 | $1.68 |
| Gross Margin | 81.9% | 86.0% |
| Operating Margin | 44.7% | 61.6% |
| Net Profit Margin | 37.4% | 50.1% |
| Free Cash Flow | $3.01B | $1.85B |
| Cumulative Free Cash Flow | $101.90B | $100.86B |
| Operating Cash Flow | $5.33B | $3.71B |
| Cash & Equivalents | $5.28B | $3.25B |
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.